CLINICAL_TRIALS ClinicalTrials.gov record with results posted

CNTO1959PSO3018: A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Guselkumab for the Treatment of Participants With Skin of Color Who Have Moderate-to-Severe Plaque Psoriasis and/or Moderate

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05272150
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-25T00:08:53.966522+00:00
Published At: 2026-06-24T00:00:00+00:00
Record Updated At: 2026-06-24
Results Posted At: 2026-06-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Plaque Psoriasis", "Scalp Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-24"
protocolSection.identificationModule.nctId: "NCT05272150"
protocolSection.identificationModule.officialTitle: "CNTO1959PSO3018: A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Guselkumab for the Treatment of Participants With Skin of Color Who Have Moderate-to-Severe Plaque Psoriasis and/or Moderate"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.